Teva Announces Updated Indication and Vial Presentation for Granix (tbo-filgrastim) Injection in United States

6 years ago

by David Miller

975 Views

Written by David Miller

JERUSALEM–(BUSINESS WIRE)–Aug. 6, 2018– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved Granix (tbo-filgrastim) Injection for a new vial presentation and…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!